Mirae Asset Global Etfs Holdings Ltd. Cassava Sciences Inc Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Cassava Sciences Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 23,294 shares of SAVA stock, worth $64,990. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,294
Previous 22,306
4.43%
Holding current value
$64,990
Previous $656,000
91.77%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SAVA
# of Institutions
190Shares Held
16.4MCall Options Held
3.49MPut Options Held
8.08M-
Black Rock Inc. New York, NY3.22MShares$8.98 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.51MShares$7.01 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.01MShares$2.81 Million0.0% of portfolio
-
State Street Corp Boston, MA997KShares$2.78 Million0.0% of portfolio
-
Ubs Group Ag931KShares$2.6 Million0.0% of portfolio
About CASSAVA SCIENCES INC
- Ticker SAVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,097,900
- Market Cap $112M
- Description
- Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...